Posts Tagged ‘side effects’

2,500 in nursing homes put at risk of death from Antipsychotics (note: death risk applies to anyone on antipsychotics)

Monday, March 8th, 2010

Fox News
March 8, 2010

Federal officials say nearly 2,500 Massachusetts nursing home residents were given powerful antipsychotic drugs last year that were not intended or recommended for their medical condition.

The Boston Globe reports that data collected by the Centers for Medicare and Medicaid Services show that 28 percent of Massachusetts nursing home residents were given antipsychotics in 2009. Of that group, more than one out of every five did not have a medical condition that called for such treatment.

Federal officials say the drugs are often given to patients with dementia, which puts them at risk for serious side effects, even death.

An official with the organization that represents the state’s nursing homes acknowledges that the number is too high and says better training is needed.

Read article:  http://www.foxnews.com/story/0,2933,588391,00.html

« Return to news items


  • Share/Bookmark

New allegations of suppressed drug data surface as thousands sue over antipsychotic drug causing weight gain/diabetes

Friday, January 29th, 2010

BBC News
January 26, 2010

The marketing team sued over a drug’s alleged side effects tried to suppress key data, an ex-employee has claimed.

Seroquel’s former UK medical adviser told the BBC he was pressured to approve promotional material which said weight gain was not an issue.

Maker AstraZeneca, which faces fresh legal action next month, said it took concerns about its conduct seriously.

In the same programme, the British Medical Journal editor urged that the medicine licensing system be reviewed.

Dr Fiona Godlee said industry should no longer provide the evaluations of its own drugs which the licensing body considered.

‘Job threat’

Thousands of patients are suing AstraZeneca in US courts, claiming the anti-psychotic drug Seroquel caused weight gain and diabetes.

The patients allege Seroquel, its second biggest selling drug worth $4.5bn (£2.7bn) a year, was marketed without adequate warning about possible side effects such as massive weight gain and the development of diabetes. However, this is denied by the company.

Read entire article:  http://news.bbc.co.uk/2/hi/health/8478924.stm

« Return to news items


  • Share/Bookmark

Harvard psychologist links America’s growing number of obese children & adults to psychiatric drug use

Friday, January 29th, 2010

InjuryBoard.com
By David Mittleman
January 29, 2010

Obesity is an epidemic–or at least a major concern for many Americans. We obsess over diet fads, exercise machines, portion control, and The Biggest Loser, all in an effort to get our ballooning waistlines in check. However, according to some researchers, we are looking in all the wrong places for the reason why we’re so fat. Instead of oversized and calorie-laden fast food meals, at least one expert is starting to wonder if the cause of our nation’s weight gain is prescription psychiatric drugs.

Paula J. Caplan, a clinician and research psychologist at Harvard University, suspects that the seemingly non-serious “side effects” of psychiatric medications are to blame for our weight problems. She argues that the sudden weight gain of many Americans occurred during the same time period that psychiatric drugs picked up in popularity–that is, the average weight of an adult has increased by 25 pounds since 1960 while prescriptions of psychiatric drugs to US adults also increased by 73% between 1996 and 2006 alone. What troubles Caplan even more so is that children aren’t left out of the equation. In fact, over the past two decades the number of obese children has tripled while prescriptions of psychiatric drugs to children from 1996-2006 increased by 50%.

Read entire article:  http://lansing.injuryboard.com/fda-and-prescription-drugs/are-psychiatric-medications-causing-your-weight-gain.aspx?googleid=277442

« Return to news items


  • Share/Bookmark

In Santa Cruz CA, where 9% of adults have taken psych drugs, advocates launch 1st Green Mental Health Care Day

Tuesday, December 29th, 2009

Kim Wein
GOOD TIMES Santa Cruz
December 28, 2009

Is Santa Cruz County one of the most drugged counties in the United States? Some might quickly reply with a yes. But it’s not for the reason you might think.

According to the Santa Cruz County Community Assessment Project Comprehensive Report for 2009, in the past 12 months, 9.2 percent of adults in Santa Cruz County have taken prescription medication for mental health or emotional problems almost daily for two weeks or more. This fact has some local medical practitioners asking: What are the consequences of having a significant portion of the population reliant on psychiatric drugs?

The issue is illuminated somewhat in The Marketing of Madness, a film recently released by Citizens Commission on Human Rights (CCHR). In it, revealing details suggest that disorders listed in the “Diagnostic and Statistical Manual of Mental Disorders” (DSM)—diseases found here are voted into existence by a panel of psychiatrists—have no proven pathology and therefore cannot be called medical diseases. According to the APA, 19 of the 27 psychiatrists on the [DSM] top panel … have financial ties to drug companies.” With an obvious conflict in interest, these psychiatrists are allowed to serve on a panel, voting in diseases with pharmaceutical money in their pockets.

Read entire article: http://www.goodtimessantacruz.com/santa-cruz-news/santa-cruz-local-news/455-drug-me-please.html

« Return to news items


  • Share/Bookmark

Paxil birth defect settlement tops list of “most impactful” lawsuit settlements for 2009

Tuesday, December 15th, 2009

Kristine B.
LawyersandSettlements.com
December 15, 2009

We’re in the countdown to year-end and looking over some of the more impactful settlements LawyersAndSettlements.com has covered over the past year. When we’re talking impactful, everyone around here has an opinion—so we had to throw in some criteria. To get the nod for impact, a settlement had to be one of two things: 1. High dollar value; or 2. Precedent-setting—or at least have the potential to influence similar cases to follow. (Sounds simple, but you try getting Stephen, John, Jaime, Michelle and Ben to settle in on just 7 settlements with just those criteria…) So here we go…7 game-changing settlements for ‘09…

1) Family takes on GlaxoSmithKline

Michelle David filed a lawsuit against GlaxoSmithKline, alleging the company’s antidepressant, Paxil was responsible for her son’s birth defects. David said she had taken Paxil while pregnant and was not aware of the potential side effects. GlaxoSmithKline said that birth defects occur in between three and five percent of all live births, regardless of Paxil use.

Read entire article: http://www.lawyersandsettlements.com/blog/7-game-changing-settlements-of-2009-02165.html

« Return to news items


  • Share/Bookmark

Pharma’s Drug Ads: From Million Dollar TV Ads to $1.7 Billion Internet Marketing Campaign

Monday, November 16th, 2009

On November 13th, 2009, Pharmaceutical companies flocked to a two-day FDA hearing into online drug advertising, which could influence their use of social media on the net. 1  Already, the explosive growth in online advertising has intensified public concerns: the pharmaceutical industry spent more than $1 billion on Internet ads last year and is projected to spend $1.7 billion on such marketing efforts in 2012, according to the Direct Marketing Association.2

Both Eli Lilly and Merck have received warning letters this year from the FDA accusing them of misleading online advertisements.3  But while the FDA scrambles to monitor online ads, who monitors the psychiatric-pharmaceutical industry’s use of front groups to indirectly market their products?

A Washington Post article of June 16, 2009 reported that an increasing number of pharmaceutical firms are turning to social media tools, such as Facebook, YouTube, Twitter and MySpace, to market their products.  It cites how a community site sponsored by drugmaker McNeil called “ADHD Allies”—aimed at adults with ADHD—was established and offered an online podcast on financial advice and an “ADHD self-assessment tool.”4

British psychiatrist Joanne Moncrieff explains how this ultimately increases drug sales because only a biomedical approach is promoted: “Drug companies…provide funds for pro drug patient and carer groups and address advertising or disease promotion campaigns to the general public…This influence has helped to create and reinforce a narrow biological approach to the explanation and treatment of mental disorders and has led to the exclusion of alternative” treatments.5

Such websites do not mention company’s product but rather market the “disease.” In advertising, it can be accomplished through a strategy known as “condition branding,” where “mental illness” can be pitched just like cars, beer or laundry detergent.  Witness the brand name “bipolar” and “social anxiety disorder” that drug companies marketed at a fever pitch.

John Read, PhD, Psychology Department, University of Auckland did an analysis of 54 random “advocacy” groups for Post Traumatic Stress Disorder (PTSD) through the Internet. The results, published in the Journal of Trauma & Dissociation this year, found 42% of the websites received drug company funding. The researchers found:

  • “Patients tend to trust these organizations to act in an unbiased manner” but as earlier researchers argued in some cases “patient organizations have become a mouthpiece for the pharmaceutical industry in influencing regulatory authorities.”
  •  “Drug company influence within the area of mental health is prevalent and now extends to the Internet. This influence is not always transparent. This study suggests that drug company sponsorship of websites leads to a greater emphasis on pharmacology in the treatment of PTSD,” Dr. Read’s report concludes.6

ADHD Allies/ADHD Moms

In June 2008 Concerta was given an expanded indication by FDA and is now indicated for patients aged 6 to 65.7 In July 2008, McNeill Pediatrics—a subsidiary of Ortho-McNeill Pharmaceuticals—launched what they called an “unbranded group” called “ADHD Moms.” ADHD Moms markets the trademarked name “Mom-bassadors” to get mothers into the Facebook page. 8

  • McNeill spuriously claims “the group is not product-specific, nor are there any advertisements for the company’s ADHD drug Concerta (methylphenidate).” Well not directly, but providing material for the site is a Dr. Quinn, a paid consultant and speaker for McNeil Pediatrics. 9  April White, who also provides content is a paid spokesperson for McNeil Pediatrics.10
  • On April 22 2009, McNeill launched a second ADHD-focused Facebook page called “ADHD Allies,” this time targeting adults.  The “Allies” are board members of another front group Attention Deficit Disorder Association (ADDA), funded by McNeill.11
  • The pharmaceutical company has trademarked “ADHD Allies” and “ADHD Moms.”  ADHD Allies was responsible for a “2008 Harris Interactive survey of 1,000 adults with ADHD.” Not surprisingly, the survey found the condition significantly affects them. 12

Log onto The Bipolar Journey: Living With Bipolar Depression website and while it does show AstraZeneca on the home page, there’s no mention of its blockbuster antipsychotic drug Seroquel, approved by the FDA in 2006 for “bipolar.”  The site looks like a patient information site providing facts about the “disease” and misleadingly saying that it may be caused by a chemical imbalance—for which there is no evidence.

It refers people to the National Alliance for the Mentally Ill (NAMI) that has received $23 million recently from at least 18 drug companies. The site shows that of 17 cites for the exhibit’s showing in 2009, 12 are conferences or events put on by NAMI.

It also links to The Depression and Bipolar Support Alliance, a group that received close to $1 million in pharmaceutical company funding in 2007.

According to an August 27 2009 press announcement, AstraZeneca launched its interactive exhibit, endorsed by New York psychiatrist Janet Taylor. The press release does not mention that Dr. Taylor has financial ties to the company.13

In 2005, global sales for Seroquel reached $2.8 billion.  October 20, 2006, company announced Seroquel was FDA approved for bipolar.14 Within a year, sales reached $3 billion and then soared again in 2008 to $4.66 billion.15

By funding social media front groups that talk only about the “disorder,” drug companies can overcome fears of running afoul of FDA regulations that govern drug advertising and “are embracing social networks to help brand and position their companies in a positive light with consumers and practitioners.”  The top 10 drug companies using social media are: Pfizer, Johnson and Johnson, Novartis, Boehringer Ingelheim, AstraZeneca US, Bayer, GlaxoSmithKline, Sanofi-Aventis, Roche, and Merck.16

This post was written by CCHR International.
Coming next from CCHR Int: Psycho Pharma Front Groups

1 “FDA Addresses Drug Ads in Online Social Media,” Red Orbit, 13 Nov. 2009.

3 “FDA Addresses Drug Ads in Online Social Media,” Red Orbit, 13 Nov. 2009.

5 Joanne Moncrief, in a “Study of the Influence of the Pharmaceutical Industry on Academic and Practical Psychiatry,” http://www.critpsynet.freeuk.com/pharmaceuticalindustry.htm

6 http://www.isst-d.org/jtd/mansell_&_read_ptsd_drug_cos_&_internet%20.pdf; Journal of Trauma & Dissociation, 10:9–23, 2009

12 “Adults ‘Facing’ ADHD: ADHD Allies™ Offers Unique Online Community for Adults with ADHD on New Facebook® Page,” http://multivu.prnewswire.com/mnr/concerta/36533/

RETURN TO BLOGS PAGE


  • Share/Bookmark

The Drugging of America: Antidepressants Most Commonly Prescribed Drugs in U.S.

Friday, September 18th, 2009

S.L. Baker
NaturalNews.com
September 18, 2009

As NaturalNews has reported in detail, antidepressants like Prozac (fluoxetine) and the growing list of similar selective serotonin reuptake inhibitor drugs (SSRIs) not only can have numerous side effects from nausea to headaches — but they’ve also been linked to horrendous suicide, problems including suicide in teens, sudden death in women and even murders. But has that stopped US doctors from prescribing the drugs or slowed down the antidepressant pill popping by Americans? Apparently not. New research shows that are now the most widely prescribed drugs in the country.

According to a report in the August issue of Archives of General Psychiatry, a journal of the American Medical Association, there has been a dramatic increase in the use of antidepressants since l996. It’s not only stressed out middle-aged folks being treated for problems caused by supposed depression, either. Perhaps the most disturbing part of the new study is that it shows a broad expansion in the patient population being put on these drugs — starting with children as young as six.

Read entire article: http://www.naturalnews.com/027054_drugs_antidepressants_health.html

« Return to news items


  • Share/Bookmark

Pharma spends billions marketing to doctors; Eli Lilly paid $22 million in first 3 months of the year

Friday, August 28th, 2009

Kris Hundley
St. Petersburg Times
August 30, 2009

There are lots of reasons why your doctor might switch your prescription to a Lilly drug.

One of them might be found in a new online database that lists how much Eli Lilly & Co. paid physicians for their expertise during the first quarter of 2009.

For the first time, Floridians can see if their doctors juggled patient appointments with speaking gigs for the maker of popular drugs like Cymbalta, Zyprexa and Cialis.

Drug companies spend billions on marketing to doctors because it works: Targeted doctors prescribe more of the company’s products.

Lilly was forced to disclose its physician pay data, which it calls a “faculty registry,” as part of a $1.4-billion settlement with the federal government earlier this year.

Read entire article: http://www.tampabay.com/news/health/medicine/drug-makers-willing-to-pay-to-get-doctors-approval/1031817

« Return to news items


  • Share/Bookmark

Former Exec for Eli Lilly blows the whistle on Pharma industry with latest book, “Side Effects: Death”

Saturday, July 25th, 2009

OpEdNews
July 25, 2009

Medical Whistleblower will be interviewing Former Eli Lilly executive, Dr. John Virapen Ph.D. on Monday July 27, 2009 at 9 AM  Central Time on BlogTalkRadio.   Dr. John Virapen has been working for more than 30 years for the pharmaceutical industry, as manager for Eli-Lilly and Novo Nordisk. He lives now in Germany and has written about his experiences in the pharmaceutical industry in a block buster book, Side Effects: Death, which is available in English, Swedish and German. This information is very especially important in the wake of the recent $1.4 billion settlement from drug maker, Eli Lilly. The drug giant, Eli Lilly, recently plead guilty to promoting its drug Zyprexa for uses not approved by the Food and Drug Administration (FDA).  Eli Lilly was found guilty of pushing Zyprexa for extra label uses, withholding research to the public and false advertising.  The criminal fine of $515 million is the largest ever in a health care case, and the largest criminal fine for an individual corporation ever imposed in a United States criminal prosecution of any kind. Eli Lilly will also pay up to $800 million in a civil settlement with the federal government and the states.

There have been years of withheld information regarding the adverse side effects of pharmaceuticals promoted by Eli Lilly,  including the possible role of Prozac in inducing suicide and homicide.  The signs of drug induced violence and suicidality were there since Prozac was first tested in premarketing trials. There were reports of Prozac’s adverse side effects of psychotic episodes; reports of completed suicides and attempted suicides, seizures, and even movement disorders.

Read entire article:  http://www.opednews.com/populum/diarypage.php?did=13885

« Return to news items


  • Share/Bookmark

Psychiatric Drugs, Violence and Suicide

Sunday, July 19th, 2009

police_tape_288x195K.L. Carlson
Former Pharmaceutical Rep.

People often go through times of depression due to job loss, relocation, loss of a loved one, divorce, and many other situations that cause us to feel insecure. Our bodies do have natural ways of dealing with these emotions especially if people use healthy means including adequate sleep, exercise, healthy eating and emotional support from friends and family.

SSRI/SNRI (Selective Serotonin Reuptake Inhibitors/Selective Norepinephrine Reuptake Inhibitors) are antidepressant drugs that interfere with the body-mind’s normal functioning. These drugs are literally mind-altering.  They can cause people to terminate loving, supportive relationships with family and friends, the very relationships that are extremely important to helping people recover from depression.  The drugs can cause hallucinations, paranoia, and mania.

There is a direct correlation with the increase of antidepressant drug use and the rise in extreme, senseless violent acts.  There are experts who have been trying to bring this to the attention of physicians, the FDA, and the public for more than a decade.  Depression is not the problem.  The drugs are the problem.

In 2001, GlaxoSmithKline was ordered to pay $6.4 million to the surviving family members after 60 year old Donald Schnell flew into a rage and killed his wife, daughter, and granddaughter only 48 hours after he began to take Paxil.

“I keep asking, when is somebody going to see this?  But we’ve been so brainwashed about drugs.  We think legal means safe,” Ann Blake Tracy, Ph.D. explains.  “Most people don’t know that LSD once was legal and prescribed as a wonder drug.  That PCP was considered to have a large margin of safety in humans. Most people don’t know that ecstasy was prescribed and sold for five years to treat depression.

The adverse effects of psychiatric drugs are regularly misdiagnosed as more signs of depression, anxiety or some other created-by-vote psychiatric disorder. Then patients are prescribed additional psychiatric drugs or the dosage is increased.  That was the case of California teenager Dominique Slater.  Only 14 years old she was on several antidepressants including Celexa and Wellbutrin. When her erratic behavior worsened her doctor prescribed double dose of Effexor.  Fifteen days later she killed herself.  She was barely a teenager yet she was prescribed multiple antidepressant drugs at high doses.  The year was 2003. Britain had already sent letters to all physicians sternly warning against the use of any of these drugs in anyone under the age of 18 years.  It took the FDA another year to issue a warning of increased suicide in youths under 18 years old.  No letters were sent to physicians.  And the drug companies created marketing campaigns specifically to get antidepressants into the offices of all types of physicians, not just psychiatrists.

More than 10 million prescriptions for antidepressants are issued each year for children younger than 18 in the U.S.  Any physician, not just psychiatrists, can write prescriptions for psychiatric drugs.  The age of children being given these powerful mind-altering drugs continues to get younger.  Ohio physicians in the month of July 2004 prescribed psychiatric drugs for 696 babies aged newborn to 3 years old covered by Medicaid.

“It’s shocking,” said Dr. Ellen Bassuk, associate professor of psychiatry at Harvard Medical School.  “These medications are not benign.  They can have dangerous side effects.  Who is being helped by children being drugged, the babies or the caregivers?”

Scientific Evidence of Antidepressants’ Effects on Newborns

“When we put pregnant women on antidepressants, they can’t get off them,” an unconcerned gynecologist told my friend C. when she told him she had spent years trying to get off the antidepressant he had prescribed to her.  Three years before this callous physician’s comments to C., the extreme health risks to the fetus had been reported in medical journals.

A study published in The New England Journal of Medicine in February 2006 reports pregnant women taking antidepressants have babies who are 6 times more likely to have primary pulmonary hypertension (PPH) or a developing lung disorder.  PPH is extremely serious. A baby’s organs such as brain, kidney and liver are stressed due to lack of oxygen.  PPH requires neonatal intensive care. PPH can be fatal and for babies who do survive there is often long-term health problems including breathing difficulties, seizures and developmental disorders.

Women taking SSRI/SNRI drugs during the first trimester of pregnancy are at 60 percent greater risk of their babies having heart defects and 40 percent greater risk of their babies suffering malformation.

“In conclusion, our results suggest that maternal exposure to fluoxetine (Prozac, Luvox, Sarafem and Symbyax) during pregnancy and lactation results in enduring behavioral alterations… throughout life,” a study reports in Pharmacology, spring 2007.  Although the study was done with mice the physiological systems are similar to humans.  There is nothing preventing drugs a pregnant woman takes from going directly into the bloodstream and then all the tissues of the fetus.  And as this study indicates, antidepressants are also transferred to the baby through the mother’s milk.

As of February 2009, the drug companies, using their puppets and financial influence, are lobbying the U.S. Senate to pass a bill called the Mothers Act.  This insane bill has already passed the U.S. House of Representatives.  Supposedly this bill is meant to address postpartum depression.  The truth is that it’s the drug industry influencing legislation in order to have more taxpayers’ money flow into drug companies’ profits.  The 1,200 drug industry lobbyists on Capitol Hill are greasing the skids well so that this dangerous legislation that will harm, not help mothers, babies, and American families will easily pass.  It’s about money, not health.

RETURN TO BLOGS PAGE


  • Share/Bookmark